32 per equity share for the year. This dividend for the year ended 31 March 2024 is subject to the approval of Members at the Annual General Meeting on 28 June 2024 and will be paid on or after 1 ...
GSK plc (NYSE:GSK) Price Target Upside: 29.94% GSK plc (NYSE:GSK), formerly known as GlaxoSmithKline, is a global pharmaceutical and healthcare corporation based in the United Kingdom that creates ...
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other ...
Shares of GlaxoSmithKline Pharmaceuticals (GSK Pharma) extended their rally for the second consecutive session on Tuesday (February 18), gaining 29% over two days. The stock had hit a 20% upper ...
The rally in GlaxoSmithKline Pharmaceuticals shares comes after the company reported robust growth in its Q3 results. The biopharma company reported its earnings for the third quarter of FY25 on ...
The United Kingdom-based pharma giant, GlaxoSmithKline Pharmaceuticals or GSK's Indian arm GSK Pharmaceuticals, saw its shares continue to rise on Tuesday as well. This is because the company made ...
The shares of GlaxoSmithKline Pharmaceuticals Ltd (GSK Pharma) jumped over 15 percent to trade at Rs 2,684 apiece on February 18, extending gains for the second straight session after releasing ...
GlaxoSmithKline Pharmaceuticals' shares surged nearly 16% as net profit rose over five-fold to Rs 229 crore for Q3 2024. The stock reached Rs 2,332.25 on BSE and Rs 2,339 on NSE. Revenue increased to ...
Shares of GlaxoSmithKline Pharmaceuticals Ltd. are trading with gains of 20% on Monday, February 17, bucking in trend in a market where most Nifty 50 constituents are trading with losses. GSK Pharma ...
New Delhi, Feb 17 (PTI) Shares of GlaxoSmithKline Pharmaceuticals on Monday surged nearly 16 per cent after the firm's net profit increased over five-fold to Rs 229 crore for the third quarter ended ...
Commenting on the results, Bhushan Akshikar, MD of GlaxoSmithKline Pharmaceuticals, highlighted the company’s strategic initiatives in strengthening its market presence and enhancing access to ...
GlaxoSmithKline Pharmaceuticals shares hit 20 per cent upper circuit in trade on BSE at Rs 2,421.3 per share. The buying on the counter came after the company posted its Q3 results. Around 9:52 AM, ...